Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.629, 2011-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost sharing suggested for UK NHS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 296, 2001-01 ,pp. :
Access to resources
Recommend
Cost effective treatment options for AS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 537, 2007-01 ,pp. :
Alemtuzumab effective in MS, but at a cost
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :
Cost effective treatment options for AS
Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. :
Tocilizumab cost effective in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 607, 2010-01 ,pp. :